卡培他滨
医学
拉帕蒂尼
肿瘤科
内科学
乳腺癌
曲妥珠单抗
癌症
转移性乳腺癌
结直肠癌
出处
期刊:Lancet Oncology
[Elsevier BV]
日期:2019-08-30
卷期号:20 (10): e562-e562
被引量:11
标识
DOI:10.1016/s1470-2045(19)30568-6
摘要
Patients with previously treated HER2-positive relapsed or metastatic breast cancer have significantly better outcomes when treated with pyrotinib plus capecitabine than with lapatinib plus capecitabine, according to a recent study.
科研通智能强力驱动
Strongly Powered by AbleSci AI